Business ❯Finance ❯Investments ❯Pharmaceuticals

Novo Nordisk

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short

Novo Nordisk's Obesity Pill Shows Modest Results, Stocks Drop